Alan Job, MD
Orthopaedic Surgery of the Spine · Bronx, NYNPI 1770080475
Payments from drug & device makers
What this record shows
This record is dominated by grants: $50,000 of the $61,167 with a category attached, or 81.7%. Medtronic accounts for 83.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $53,470 and has fallen 93.0% since, to $3,742 in 2025.
Across 56 payments — averaging $1092.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$51K
- Spineart USA Inc$5K
- Stryker$3K
- Synthes GmbH$819
- Orthofix Medical, Inc.$233
- Cerapedics Inc.$202
- plus $572 from 5 others
What the payments were for
- Grants$50,00082%
- Travel & lodging$6,09310%
- Food & beverage$4,6998%
- Education$3751%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 10 | $51,346 |
| Spineart USA Inc | 16 | $5,415 |
| Stryker | 19 | $2,581 |
| Synthes GmbH | 2 | $819 |
| Orthofix Medical, Inc. | 2 | $233 |
| Cerapedics Inc. | 1 | $202 |
| BD | 1 | $183 |
| Si-bone, Inc. | 1 | $173 |
| Vertex | 1 | $123 |
| Baxter Healthcare | 1 | $48 |
| Johnson & Johnson(2 entities) | 2 | $46 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CD HORIZON SPINAL SYSTEM$50,104
- CASCADIA INTERBODY SYSTEM$1,141
- PERLA C$1,131
- Juliet LL$1,122
- PANGEA$882
- O-ARM$375
- UNID_PASS$372
- N/A$318
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$202
- Channel Drain$183
- ZEVO ANTERIOR CERVICAL PLATE SYSTEM$168
- Perla TL$150
- FIREBIRD NXG$136
- MAZOR X SYSTEM$122
- SACRLET AC-T INSTRUMENTATION$112
How this compares
$61,167 in reported general payments places this provider in the 70th percentile of 161 orthopaedic surgery of the spine providers in New York.
See all orthopaedic surgery of the spine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 70 | $2,343 |
| Meloxicam | 34 | $176 |
| Methylprednisolone | 21 | $163 |
| Gabapentin | 19 | $158 |
| Cyclobenzaprine Hcl | 30 | $150 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Bronx
- Joshua AuerbachBronx$140K
- Ashley SimelaBronx$32K
- Hansen YuanSyracuse$31.7M
- Frank SchwabNew York$5.1M
- Han KimNew York$3.9M
- Todd AlbertNew York$2.7M
- Jeffrey SpivakNew York$1.3M
- Aaron BucklandNew York$1M
- Seth NeubardtWhite Plains$902K
- Sheeraz QureshiNew York$828K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.